Roberta Passiatore

Has grant

Researcher

University of California, Irvine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Neurotransmitter systems underlying resting-state inter-individual variability in association with psychotic-like experiences and polygenic risk score for schizophrenia

Open Date: 2022-12-01

Close Date: 2023-02-01

Grant: Close

Interindividual variability of neural recruitment supporting cognition

Open Date:

Close Date: 2023-01-01

Articles (10)

Background People with schizophrenia develop more chronic diseases at a younger age and die younger than people in the general population. It has been hypothesized that this excess morbidity and mortality could be partially due to accelerated aging in schizophrenia. If true, this would motivate the development of ‘gero-protective’ interventions to reduce chronic disease burden in schizophrenia. However, it has been difficult to test this hypothesis, in part, due to the limited ability to measure aging in samples of people with schizophrenia. Methods We utilized a novel neuroimaging biomarker of the longitudinal pace of aging, DunedinPACNI, to test for accelerated whole-body aging in schizophrenia across four neuroimaging datasets (total N = 2,096, 48% female) accessed through the Lieber Institute for Brain Development, the University of Bari Aldo Moro, and the North American Prodrome Longitudinal Study – 3. Results We found consistent evidence of faster DunedinPACNI in schizophrenia compared with controls. In contrast, youth at clinical-high risk for psychosis did not have faster DunedinPACNI compared to controls. Unaffected siblings of patients also did not have faster DunedinPACNI than controls. Faster DunedinPACNI in schizophrenia was not explained by tobacco smoking or antipsychotic medication use. Conclusions The results support the hypothesis that schizophrenia is accompanied by accelerated aging. Results were inconsistent with some of the most obvious explanations for accelerated aging in schizophrenia (familial risk, smoking, and iatrogenic medication effects). Research should aim to uncover why people who have schizophrenia age rapidly, as well as the utility of early disease-risk monitoring and anti-aging interventions in schizophrenia.

Year:

2026

Encoding new memories relies on functional connections between the medial temporal lobe and the frontoparietal cortices. Multiscan fMRI showed changes in these functional connections before and after memory encoding, potentially influenced by the thalamus. As different thalamic nuclei are interconnected with distinct cortical networks, we hypothesized that variations in corticothalamic recruitment may impact individual memory performance. We used a multiscan fMRI protocol including a resting-state scan followed by an associative memory task encompassing encoding and retrieval phases, in two independent samples of healthy adults ( N 1 = 29, mean age = 26, males = 35%; N 2 = 108, mean age = 28, males = 52%). Individual activity and functional connectivity were analyzed in the native space to minimize registration bias. By modeling the direct and indirect effects of corticothalamic recruitment on memory using structural equation modeling, we showed a positive association between resting-state functional connectivity of the medial thalamic subdivision within the frontoparietal network and memory performance across samples (effect size R 2 ranging between 0.27 and 0.36; p -values between 0.01 and 4 × 10 −5 ). This direct relationship was mediated by decreased activation of the anterior subdivision during encoding ( R 2 ranging between 0.04 and 0.2; p -values between 0.05 and 0.006) and by increased activation of the medial subdivision during retrieval ( R 2 ranging between 0.04 and 0.2; p -values between 0.05 and 0.004). Moreover, three distinct clusters of individuals displayed different corticothalamic patterns across memory phases. We suggest that associative memory encoding relies on the distinct corticothalamic pathways involving medial thalamic recruitment and suppression of anterior subdivision to support the successful encoding of new memories.

Year:

2025

Year:

2025

Alterations in cognitive and neuroimaging measures in psychosis may reflect altered brain‐behavior interactions patterns accompanying the symptomatic manifestation of the disease. Using graph connectivity‐based approaches, we tested the brain‐behavior association between cognitive functioning and functional connectivity at different stages of psychosis. We collected resting‐state fMRI of 204 neurotypical controls (NC) in two independent cohorts, 43 patients with chronic psychosis (PSY), and 22 subjects with subthreshold psychotic symptoms (STPS). In NC, we calculated graph connectivity metrics and tested their associations with neuropsychological scores. Replicable associations were tested in PSY and STPS and externally validated in three cohorts of 331, 371, and 232 individuals, respectively. NC showed a positive correlation between the degree centrality of a right prefrontal‐cingulum‐striatal circuit and total errors on Wisconsin Card Sorting Test. Conversely, PSY and STPS showed negative correlations. External replications confirmed both associations while highlighting the heterogeneity of STPS. Group differences in either centrality or cognition alone were not equally replicable. In four independent cohorts totaling 1,203 participants, we identified a replicable alteration of the brain‐behavior association in different stages of psychosis. These results highlight the high replicability of multimodal markers and suggest the opportunity for longitudinal investigations that may test this marker for early risk identification.

Year:

2025

Year:

2024

Background Previous evidence suggests that early life complications (ELCs) interact with polygenic risk for schizophrenia (SCZ) in increasing risk for the disease. However, no studies have investigated this interaction on neurobiological phenotypes. Among those, anomalous emotion-related brain activity has been reported in SCZ, even if evidence of its link with SCZ-related genetic risk is not solid. Indeed, it is possible this relationship is influenced by non-genetic risk factors. Thus, this study investigated the interaction between SCZ-related polygenic risk and ELCs on emotion-related brain activity. Methods 169 healthy participants (HP) in a discovery and 113 HP in a replication sample underwent functional magnetic resonance imaging (fMRI) during emotion processing, were categorized for history of ELCs and genome-wide genotyped. Polygenic risk scores (PRSs) were computed using SCZ-associated variants considering the most recent genome-wide association study. Furthermore, 75 patients with SCZ also underwent fMRI during emotion processing to verify consistency of their brain activity patterns with those associated with risk factors for SCZ in HP. Results Results in the discovery and replication samples indicated no effect of PRSs, but an interaction between PRS and ELCs in left ventrolateral prefrontal cortex (VLPFC), where the greater the activity, the greater PRS only in presence of ELCs. Moreover, SCZ had greater VLPFC response than HP. Conclusions These results suggest that emotion-related VLPFC response lies in the path from genetic and non-genetic risk factors to the clinical presentation of SCZ, and may implicate an updated concept of intermediate phenotype considering early non-genetic factors of risk for SCZ.

Year:

2024

Year:

2024

Year:

2024

Cognitive dysfunctions are core-enduring symptoms of schizophrenia, with important sex-related differences. Genetic variants of the DTBPN1 gene associated with reduced dysbindin-1 protein (Dys) expression negatively impact cognitive functions in schizophrenia through a functional epistatic interaction with Catechol-O-methyltransferase (COMT). Dys is involved in the trafficking of dopaminergic receptors, crucial for prefrontal cortex (PFC) signaling regulation. Moreover, dopamine signaling is modulated by estrogens via inhibition of COMT expression. We hypothesized a sex dimorphism in Dys-related cognitive functions dependent on COMT and estrogen levels. Our multidisciplinary approach combined behavioral-molecular findings on genetically modified mice, human postmortem Dys expression data, and in vivo fMRI during a working memory task performance. We found cognitive impairments in male mice related to genetic variants characterized by reduced Dys protein expression (p Bonferroni = 0.0001), as well as in male humans through a COMT/Dys functional epistatic interaction involving PFC brain activity during working memory (t(23) = −3.21; p FDR = 0.004). Dorsolateral PFC activity was associated with lower working memory performance in males only ( p = 0.04). Also, male humans showed decreased Dys expression in dorsolateral PFC during adulthood (p FDR = 0.05). Female Dys mice showed preserved cognitive performances with deficits only with a lack of estrogen tested in an ovariectomy model (p Bonferroni = 0.0001), suggesting that genetic variants reducing Dys protein expression could probably become functional in females when the protective effect of estrogens is attenuated, i.e., during menopause. Overall, our results show the differential impact of functional variants of the DTBPN1 gene interacting with COMT on cognitive functions across sexes in mice and humans, underlying the importance of considering sex as a target for patient stratification and precision medicine in schizophrenia.

Year:

2024

Year:

2023

Collaborators (19)

Mar Fatjó-Vilas

Senior Researcher

University of Barcelona

SPAIN
View details

Maxwell Elliott

Faculty, Assistant Professor

University of Minnesota

UNITED STATES
View details

Giuseppe Stolfa

MEG Staff Scientist - Magnetoencephalography Lab

University of Bari Aldo Moro

ITALY
View details

Mirabel Pelton

Research Associate

University of Cambridge

UNITED KINGDOM
View details

Erich Studerus

Lecturer / Researcher

University of Applied Sciences and Arts Northwestern Switzerland

SWITZERLAND
View details

Stephan Ruhrmann

Lecturer

University of Cologne

GERMANY
View details

Mariateresa Ciccarelli

Università degli Studi di Napoli Federico II

ITALY
View details

Neeltje van Haren

professor

Erasmus MC

NETHERLANDS
View details

Juergen Dukart

Group leader

Forschungszentrum Jülich

GERMANY
View details

Adrian Preda

University of California Irvine School of Medicine

UNITED STATES
View details

Adriana Carol Eleonora Graziano

Docenti di ruolo di IIa fascia

Università degli Studi di Enna Kore

ITALY
View details

Tae Young Lee

Research Associate Professor

Seoul National University College of Medicine

SOUTH KOREA
View details

David Popovic

Max Planck Institute of Psychiatry

GERMANY
View details

Giulio Pergola

Associate Professor of Psychiatry and Behavioral Sciences

Johns Hopkins University

UNITED STATES
View details

Francesco Papaleo

Tenured Senior Researcher and group leader

Istituto Italiano di Tecnologia

ITALY
View details

Enrico D'Ambrosio

Clinical Lecturer (RTDa)

University of Bari Aldo Moro

ITALY
View details

Jessica Turner

Professor

The Ohio State University Wexner Medical Center

UNITED STATES
View details

Nicola Sambuco

Assistant Professor

University of Bari Aldo Moro

ITALY
View details

Henri Pesonen

Assistant Professor

University of Tampere

FINLAND
View details